Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Powers

Showing results (241-250 of 255) with videos related to

Pageof 26
Sort By:
Molecular Cancer Therapeutics|April 11, 2022
Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor ImmunityDana Piovesan, Joanne B L Tan, Annette Becker, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2011
Discovery of amide replacements that improve activity and metabolic stability of a bis-amide smoothened antagonist hitMatthew L Brown, Wade Aaron, Richard J Austin, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2010
Design of 1-piperazinyl-4-arylphthalazines as potent Smoothened antagonistsBrian S Lucas, Wade Aaron, Songzhu An, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 3, 2011
Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozoleTatiana M Prowell, Amanda L Blackford, Celia Byrne, et al.
Journal of Medicinal Chemistry|March 28, 2020
Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73Joel W Beatty, Erick A Lindsey, Rhiannon Thomas-Tran, et al.
Breast Cancer Research and Treatment|November 15, 2011
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancerMichaela J Higgins, Tatiana M Prowell, Amanda L Blackford, et al.
British Journal of Cancer|January 16, 2014
Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and ratsM J Walters, K Ebsworth, R D Berahovich, et al.
Journal of Medicinal Chemistry|April 29, 2026
Discovery of Casdatifan, Part I: Design and Characterization of Tetrahydroquinoline Inhibitors of Hypoxia-Inducible Factor-2αGuillaume Mata, Artur K Mailyan, Samuel L Drew, et al.
Journal of Medicinal Chemistry|July 3, 2020
Discovery of AB680: A Potent and Selective Inhibitor of CD73Kenneth V Lawson, Jaroslaw Kalisiak, Erick A Lindsey, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ InhibitorsDillon H Miles, Xuelei Yan, Rhiannon Thomas-Tran, et al.
Pageof 26

Showing results (241-250 of 255) with videos related to

Sort By:
Pageof 26
Molecular Cancer Therapeutics|April 11, 2022
Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor ImmunityDana Piovesan, Joanne B L Tan, Annette Becker, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2011
Discovery of amide replacements that improve activity and metabolic stability of a bis-amide smoothened antagonist hitMatthew L Brown, Wade Aaron, Richard J Austin, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2010
Design of 1-piperazinyl-4-arylphthalazines as potent Smoothened antagonistsBrian S Lucas, Wade Aaron, Songzhu An, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 3, 2011
Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozoleTatiana M Prowell, Amanda L Blackford, Celia Byrne, et al.
Journal of Medicinal Chemistry|March 28, 2020
Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73Joel W Beatty, Erick A Lindsey, Rhiannon Thomas-Tran, et al.
Breast Cancer Research and Treatment|November 15, 2011
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancerMichaela J Higgins, Tatiana M Prowell, Amanda L Blackford, et al.
British Journal of Cancer|January 16, 2014
Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and ratsM J Walters, K Ebsworth, R D Berahovich, et al.
Journal of Medicinal Chemistry|April 29, 2026
Discovery of Casdatifan, Part I: Design and Characterization of Tetrahydroquinoline Inhibitors of Hypoxia-Inducible Factor-2αGuillaume Mata, Artur K Mailyan, Samuel L Drew, et al.
Journal of Medicinal Chemistry|July 3, 2020
Discovery of AB680: A Potent and Selective Inhibitor of CD73Kenneth V Lawson, Jaroslaw Kalisiak, Erick A Lindsey, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ InhibitorsDillon H Miles, Xuelei Yan, Rhiannon Thomas-Tran, et al.
Pageof 26